Overview

Study on Pharmacokinetics

Status:
Completed
Trial end date:
2014-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of the coadministration of multiple doses of BMS-663068 on the systemic exposure of rosuvastatin.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
ViiV Healthcare
Collaborator:
GlaxoSmithKline
Treatments:
Fostemsavir
Rosuvastatin Calcium